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Abstract
Dr Anne Merriman is the founder of Hospice Africa and Hospice Africa Uganda. She is presently Director of Policy
and International Programmes. Here she tells the story of how HAU was founded. Dr Richard Harding is an aca-
demic researcher working on palliative care in Sub-Saharan Africa. This paper described Dr Merriman’s experience
in pioneering palliative care provision. In particular it examines the steps to achieving wider availability of opioids
for pain management for those with far advanced disease. Hospice Africa Uganda has been a model facility in
achieving high quality clinical care embedded in a strategy of advocacy and education, using a multifaceted
approach that has addressed logistical, policy and legislative barriers. Until 1990 control of severe pain in Sub-
Saharan Africa was non-existent except in Zimbabwe and S Africa. Oral affordable morphine was brought to Kenya
through Nairobi Hospice that year, and to Uganda through Hospice Africa Uganda in 1993. This paper offers an
example of a highly effective and cost efficient model of care that has transformed the ability to humanely man-
age the problems of those with terminal illness, and to offer a culturally appropriate “good death”. Thus it is now
possible to complete the ethical circle of care in resource poor circumstances.
Background
Terminal disease: the need for palliative care
Sub-Saharan Africa faces a very high burden of incurable
terminal disease. During 2007 there were 22.5 million
people living with HIV infection; 1.7 million adults and
children became infected with HIV; and 1.6 million died
of AIDS (UNAIDS). The burden of cancer is just begin-
ning to be understood and receive attention with clinical
research and policy. The burden of other non-malignant
diseases is unknown, although heart failure is recognized
as a leading cause of death in Southern Africa. Palliative
care can relieve the suffering of patients and families
affected by these diseases and a strong body of evidence
has demonstrated this [1]. The pain, symptoms, insight
and anxiety associated with HIV can also be controlled
under palliative care [2]. For this reason, policy and legal
frameworks have sought to remove this unnecessary suf-
fering and to promote cheap and effective palliative care
as both a public health issue and as a human right [3].
Medical ethics requires that we “do no harm”. Leaving
my patient in pain in the era when pain relief and symp-
tom control is affordable, is breaking our ethical code.
Since the modern palliative care speciality was devel-
oped and grew in the 1960’s across Western Europe,
Australia and North America it has (to a greater or lesser
degree) become integrated into the health system. The
palliative care needs of a range of patients and families
can be met (although still only a proportion of those who
could benefit actually get access). Therefore it is difficult
to imagine, and impossible to justify, a country where
there is no medicine for severe pain. This, however, is the
case for many countries in Africa today. While there are
centres of excellence providing care, education and advo-
cacy, they are few and far between [4,5]. To reach the
poorest and those suffering in an appropriate and ethical
manner, a public health policy needs to be accepted and
delivered in every country.
What is palliative care?
WHO defines palliative care as follows [6]:
“Palliative care is an approach that improves the qual-
ity of life of patients and their families facing the
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problem associated with life-threatening illness, through
the prevention and relief of suffering by means of early
identification and impeccable assessment and treatment
of pain and other problems, physical, psychosocial and
spiritual. Palliative care:
• provides relief from pain and other distressing
symptoms;
• affirms life and regards dying as a normal process;
• intends neither to hasten or postpone death;
• integrates the psychological and spiritual aspects of
patient care;
• offers a support system to help patients live as
actively as possible until death;
• offers a support system to help the family cope
during the patients illness and in their own
bereavement;
• uses a team approach to address the needs of
patients and their families, including bereavement
counselling, if indicated;
• will enhance quality of life, and may also positively
influence the course of illness;
• is applicable early in the course of illness, in con-
junction with other therapies that are intended to
prolong life, such as chemotherapy or radiation ther-
apy, and includes those investigations needed to bet-
ter understand and manage distressing clinical
complications.”
In summary, palliative care is appropriate for any
patient with an incurable, progressive and life threaten-
ing illness, and should be provided from the point of
diagnosis until the end of life- and should provide
bereavement support for family members if required. It
is patient focused rather than disease oriented, holistic,
and can be provided alongside potentially curative
options. Indeed, palliative care is entirely necessary
alongside antiretroviral therapy due to the distressing
and complex symptoms experienced by those living with
what remains an incurable terminal disease [7,8]. Pallia-
tive care is multi professional with recognition of the
input of nurses, doctors, social workers, spiritual care
providers and allied health professionals (where
resources permit).
The cornerstone of palliative care is the relief of pain
and other distressing symptoms- although palliative care
cannot be said to be present if pain control is the only
intervention available. My patient, in severe physical
pain, is unable to accept the holistic approach until pain
is relieved. Other dimensions of psychological and spiri-
tual pain must also be assessed and managed.
The introduction of morphine is the focus of this
paper, and is the success that enabled the provision of
cheap and effective palliative care to those who are in
severe pain. Previously there was no relief for these
patients. Thus they were unable to think or make deci-
sions, have autonomy, for themselves and their families.
Once affordable oral morphine, suitable for use in the
home is available, it is against justice for this treatment,
prescribed at the hands of trained and legal prescribers,
to be inhibited by bureaucratic channels in country.
The founding of Hospice Africa Uganda
The introduction of this essential component of health
care was a particular challenge in an African country
such as Uganda in 1993. Uganda, which lacks economic
resources, has few doctors (1: 19,000 population), and
nurses (1:5,000 population) and where 57% of the popu-
lation never see a health worker. Traditional healers are
the first port of call in illness, and there is 1 traditional
healer to 450 population. These traditional healers are
holistic in their approach and culturally more acceptable
to those in the village than Western medicine which can
be expensive. Curative options are usually few for people
who present with cancer- firstly they present very late,
as they spend some time with the traditional healer, fear
hospitals and have very little money. There is also only
one source of radiotherapy and chemotherapy and that
is in Kampala, far away from most Ugandan dwellings,
and cannot meet the needs of all patients.
In 1993, Hospice Africa Uganda (HAU) was estab-
lished [9,10], with the vision of facilitating the initiation
and expansion of palliative care throughout Africa [11].
The aim was to create an affordable and culturally
acceptable model in an African country, which could be
adapted to the needs of other African countries. The
Hospices and palliative care services in African countries
would have an ethos to guide them to care for patient
and family in this special time of life (although of course
South Africa and Zimbabwe had an earlier history of the
introduction of hospice). After a feasibility study of
countries requesting such a service, Uganda was chosen
because of the trust it had established in 1993 of the
International communities, the great increase in cancers
due to a high prevalence of HIV and the commitment
of the Ministry of Health to support relief of the suffer-
ing of so many Ugandans by importing an affordable
form of oral morphine which could be used in the
home.
Hospice Africa Uganda commenced with very little
funding, and began providing principally a home clinical
service with the addition of a hospital consultation ser-
vice. Working in partnership with the Ministry of
Health commenced immediately. Teaching at Makerere
University for undergraduate and post graduate doctors
and for nurses in training was also initiated. Thus all
doctors who have qualified to practice medicine since
1994 have been trained in palliative care. This year, the
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first unit of palliative care was commenced in Makerere
University under Internal Medicine.
With the help of the Ministry of Health, oral afford-
able morphine was brought into Uganda in September
1993. This meant importing powder and making up the
oral morphine using a formula perfected in Singapore
during Dr Merriman’s seven years there, and used for
the first time in Africa in Nairobi Hospice 1990-2.
Among the first patients, at the first Christmas, was a
little boy of 7, named Bashir. He had had a forequarter
amputation for osteosarcoma of the scapula. When he
was referred to Hospice he already had cancer in sec-
ondary sites including the liver. He was in severe pain
from the operation, and the skin grafts to the stump.
His grandmother panicked when he developed malaria
and she wanted to take him home to die. Granny having
told hospital staff he lived 20 kms away, Dr Merriman,
now alone as the little team had gone to their homes
for Christmas, set out for home with a young interpreter
from the ward caring for another patient. Thus they
found that home was 60 kms away and the last 20 kms
required them to transport him up a mountain! They
managed to reach there in the donated 4WD, and then
the team were committed to visiting him twice weekly
until he died 6 weeks later. Thanks to the fact that he
had morphine, he died a happy child and at peace.
Without palliative care, and in particular without the
availability of morphine to control his pain, this boy
would have had no opportunity for a pain free and
peaceful end to his life. His family would have suffered
alongside him.
More than 16,000 patients and families have since
received such care from Hospice Africa Uganda- and
many more receive high quality palliative care from doc-
tors, nurses, and other health professionals trained by
HAU initially.
Legislative change and specialist training to increase
access
We realised that in order to make pain control a reality
for all those who needed it, we had to increase the num-
ber of prescribers so that opioids could be accessed by
patients across a range of health care settings and dis-
tricts. In 2002, the Government agreed to change the
statute. The revolutionary change enabled a new cadre
of opioid prescribers: midwives were already allowed by
statute to prescribe pethidine. To the same statute was
added that nurses/clinical officers who had successfully
undergone training at HAU for nine months and subse-
quently registered with the Ministry of Health, could
prescribe morphine.
From 2000, due to a millennium grant from the Brit-
ish Royal Air Force, a similar programme of introducing
advocacy for affordable morphine and training health
professionals in parallel with morphine availability was
rolled out initially to Tanzania and later to other coun-
tries. We were able to achieve this through a strategic
advocacy approach to influence governments, health
professionals, Universities and other health training
institutions. Morphine is now available in 11 countries
in Africa with the consent of their Governments. How-
ever, although there is a strong desire for professionals
to be able to prescribe and control pain, and the train-
ing provides the skills to do this, experience has shown
us that the provision of training is not enough to ensure
that pain relief is delivered. Health professionals need
the subsequent support and mentoring of someone with
African experience to work side by side with them, to
introduce record keeping, monitoring and evaluation,
organisational development and all those aspects of a
sustainable organisation relevant to, and affordable in,
their own unique circumstances.
Less than a quarter of African countries have now
affordable oral morphine available. To address this pro-
blem, a combination of advocacy, education and training
is required to ensure and maintain good analgesia for
those in need. Again, training is vital and needs to come
from African success stories. We require models of care
and drug options that are relevant to the local context-
and evidence-based palliative care needs to be founded
on research and practice that has been shown to be
effective and feasible in African settings.
Morphine and end of life care in the home:
Hospice Africa’s experience
Methods of delivery
Patients in Africa prefer to die in their own homes
[12-14]. Our focus has been on critical care and end of
life care in the home since 1993. However, we do attend
hospitals on consultation and subsequently follow the
patients up at home.
For pain relief to be possible continuously in the home,
morphine needs to be given orally. The patient and
family are trained in giving morphine at regular intervals
so that the pain does not return. They are instructed in
giving an extra dose for breakthrough pain and the num-
ber of extra doses used, are calculated to adjust the daily
dose at the next visit of the team (Figure 1).
Which route of administration?
In 1993, we arrived with a donation of 5 syringe drivers
for parenteral morphine. We used them 3 times the first
year, twice the second and never since.
Firstly we can effectively manage pain with oral mor-
phine. If the problems of high or low intestinal obstruc-
tion occur (obstruction from cancer of the oesophagus,
relatively common and situated high) or ovary (not so
common and lower down according to the site of the
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metastases), we then use concentrated morphine
dripped into the mouth and this is absorbed from the
buccal mucosa with good effect. Occasionally we use
MST (slow release morphine tablets) rectally, but this is
expensive.
Managing opioid side effects
Providing a laxative for the anticipated constipation has
proved a challenge as the laxative of choice, sennakot is
expensive and not always available. Bisacodyl has greater
availability at a cost. We are now prescribing the seeds
of paw paw, dried and crushed, one to five teaspoons at
night. This gives very good results and paw paw fruits
are readily available [see Additional file 1]. Then we
turn to the margarine for the high or low impaction.
One dessertspoon taken before breakfast lubricates
impacted stool. We manage most constipation with this
regime while continuing with paw paw seeds and occa-
sionally adding in bisacodyl.
Neuropathic and bone pain
Morphine is not the treatment of choice for all pains,
and neuropathic pain and bone pain are treated by
conventional means, usually antidepressants or anti
epileptic medications for neuropathic pain not
responding to oral morphine and non steroidal anti
inflammatory drugs (NSAIDS) for bone pain [15]. Our
choice of medication is limited by cost and availability,
but we do relieve most pains. Some of the medications
usually prescribed for HIV neuropathic pain such as
gabapentin are prohibitively expensive for use in our
setting. To manage neuropathic pain of herpes zoster,
we are now using the milk of the frangipani tree [16],
[see Additional file 2]. This is applied three times a
day to the affected dermatomes, before the vesicles
appear and later for post herpetic neuralgia (see refer-
ence [17]).
Lessons from morphine production in Uganda
The process that has been established for the safe use of
opioids for home palliative care in Uganda is as follows.
1. Import morphine powder from supplier: appropriate
paper work and Government acceptance of the require-
ments for the country taken into account through the
National Drug Authority.
2. Morphine powder is transferred to the dispenser.
The dispenser is overseen by a registered pharmacist.
3. Morphine is made up as follows [17]:
a) Equipment required:
1. an accurate scale (usually an electronic scale
capable of weighing tiny amounts of powder)
2. Ability to boil and filter water
b) Powder is weighed and mixed with boiled, filtered
water [see Additional file 3].
c) The preservative, bronopol is added and the solu-
tion diluted with the required amount of water to
make it in the following strengths:
1 mg per ml,
10 mgs per ml and
20 mg per ml.
d) Each strength is colour coded: green for 1 mg per
ml, pink for 10 mgs per ml and blue for 20 mgs per
ml. The colour is cake colouring.
4. The liquid is now poured into recycled plastic water
bottles. These bottles are washed carefully, in the phar-
macy, before use. The patient is also provided with a
5 ml syringe without a needle. These are soon to be
replaced with cups because of the moulded needles to
syringes now being produced. With the syringe, they are
shown how to draw it up, by pouring the liquid into the
lid of the bottle, which holds about 5 mls. With the
cups it will be poured in directly and measured.
5. The patient or relative receives the morphine from
the dispenser. The person who collects signs the Con-
trolled Drugs book.
The formula for oral morphine, as used in Hospice
Africa Uganda, is found in the “Blue Book” (see refer-
ence [17]).
Patients and families are given a leaflet with instruc-
tions to keep the medicine out of the reach of children.
The leaflet also explains about the use of morphine. It is
in the local language as well as English. The patient and
relative are asked to return any unused morphine, and if
this is not possible because of distance, to destroy it (e.
g. put it down pit latrine) and to note how much they
destroyed.
The cost of morphine in Uganda is low. 500 mgs of
morphine diluted to 500 mls is the cost of a loaf of bread.
The average dose controlling pain in our patients is 30
mgs per day. Therefore, with morphine 5 mgs being
taken 4 hourly and a double dose at night, the bottle lasts
the average patient 10 days allowing for break through
doses of the regular 4 hourly dose if required.
Figure 1 Principles of pain relief.
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Replicating our successes in other African
Countries
This formula and our training is now being carried to
countries where Governments have agreed to import
powdered morphine. Advocacy to Governments, medical
schools and training schools is bringing pain control to
more and more patients, but there is still a huge need.
Critical illness in the home and end of life care is
being provided in a small number of countries by hos-
pice and palliative care organisations. HAU has shown
how commencing from very little, with the support of
Government and networking organisations, pain control
opens the door to providing holistic care to the patient
and family. The evaluation of our public health
approach to expanding the availability of morphine has
demonstrated that any fears of opioids being diverted
from health care into the hands of recreational users are
unfounded, and that systemic analysis of the opioids
supply chain is essential to unblock the system [18].
However, we also identified that there are problems as
there are many steps to be taken to make this effective,
with many rules and regulations which prevent our
patients getting acceptable pain control in some of the
Government health systems.
We have identified a few challenges in the replication
of our Ugandan successes in other countries. These are
observed in variation in price, in the way patients are
instructed and reinforcing myths about addiction, in
reinventing the wheel for the right formulae, strengths
and storage. These delays exhibit maleficence. There is
physical harm to the patient, suffering for the patient
and family.
4In visiting other African countries, we recently
found that the cost of morphine in one was 5 times
that in Uganda, posing a significant challenge to mod-
els of affordable pain management and palliative care
[19]. In another country, a pharmacist was questioning
each patient or relative at the pharmacy as to why they
were taking an addictive drug and reducing the dose if
he anticipated a stock out. Another pharmacist in a
Muslim country was using a formula made up with
alcohol as preservative when this is not acceptable to
the Muslim. There is an urgent ethical need for those
of us who have experienced success to share experi-
ences with those initiating care and facing challenges
to provide sustainable, affordable and effective models
of care.
Conclusion
Getting the system right so that morphine is available
and reaches those in need is the beginning of the holis-
tic approach. There are many other pains beside physi-
cal pain, and that may be as distressing: psychological,
spiritual and social problems, which must be addressed.
We have focused here on opioids as a specific challenge,
but the effective management of these other problems
also require urgent attention. Effective analgesia and the
availability of opioids is essential to allow us to then
approach the range of holistic needs of a patient who is
in severe pain and has a terminal prognosis. Hospice
Africa, together with other established palliative care
services and networking with the more recently estab-
lished regional advocacy organisation, the African Pallia-
tive Care Association, are working together to increase
the coverage, and ensure quality, throughout Africa for
those in need.
Oral morphine, made up near to the patients in need,
is now recognised as the most affordable and effective
way to control severe pain for cancer and AIDS, in the
African situation. Having proved that this affordable
method works, we, who witness the terrible suffering
still going on in Africa from cancer, AIDS and other dis-
eases, are ethically bound to try and make it reach all in
need in Africa. Only thus can we bring dignity of life
and death [20], based on the four pillars of ethics, to
those in need.
Working with limited resources and in a different cul-
tural setting, certain observations have been made which
might, with further research, assist pain control methods
and palliative care in more developed countries.
Additional material
Additional file 1: paw paw (papaya) fruit whose seeds are dried,
then crushed to be used to anticipate constipation from morphine
use.
Additional file 2: The frangi pani tree, available in most tropical
climates, produces a milk when a twig is snapped off, which when
collected and applied to the affected area of herpes zoster,
paralyses sensory fibres and controls the neuropathic pain for 8
hours.
Additional file 3: Peter Mikajo, Dispenser at HAU, prepares
morphine powder before weighing while making up liquid
morphine.
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